
Paul E. Zarek
Examiner (ID: 18450)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1617, 1628, 4161 |
| Total Applications | 773 |
| Issued Applications | 369 |
| Pending Applications | 1 |
| Abandoned Applications | 407 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7040271
[patent_doc_number] => 20050159317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Agricultural chemical component and decomposer for residual agricultural chemical'
[patent_app_type] => utility
[patent_app_number] => 11/012103
[patent_app_country] => US
[patent_app_date] => 2004-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4872
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20050159317.pdf
[firstpage_image] =>[orig_patent_app_number] => 11012103
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/012103 | Agricultural chemical component and decomposer for residual agricultural chemical | Dec 15, 2004 | Issued |
Array
(
[id] => 4989495
[patent_doc_number] => 20070155836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Steroids having a mixed androgenic and progestagenic profile'
[patent_app_type] => utility
[patent_app_number] => 10/584006
[patent_app_country] => US
[patent_app_date] => 2004-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4764
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20070155836.pdf
[firstpage_image] =>[orig_patent_app_number] => 10584006
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/584006 | Steroids having a mixed androgenic and progestagenic profile | Dec 14, 2004 | Issued |
Array
(
[id] => 4903601
[patent_doc_number] => 20080113014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Method for Screening for Compounds Safe for Gastric Mucosa'
[patent_app_type] => utility
[patent_app_number] => 10/597483
[patent_app_country] => US
[patent_app_date] => 2004-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2853
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113014.pdf
[firstpage_image] =>[orig_patent_app_number] => 10597483
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/597483 | Method for Screening for Compounds Safe for Gastric Mucosa | Dec 14, 2004 | Abandoned |
Array
(
[id] => 6983860
[patent_doc_number] => 20050153930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Inhibition of a novel calcium injury current that forms in nuerons during injury prevents neuronal cell death'
[patent_app_type] => utility
[patent_app_number] => 11/008258
[patent_app_country] => US
[patent_app_date] => 2004-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13069
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153930.pdf
[firstpage_image] =>[orig_patent_app_number] => 11008258
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/008258 | Inhibition of a novel calcium injury current that forms in nuerons during injury prevents neuronal cell death | Dec 9, 2004 | Abandoned |
Array
(
[id] => 8214587
[patent_doc_number] => 08193227
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-05
[patent_title] => 'HIV protease inhibiting compounds'
[patent_app_type] => utility
[patent_app_number] => 11/009841
[patent_app_country] => US
[patent_app_date] => 2004-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 167755
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/193/08193227.pdf
[firstpage_image] =>[orig_patent_app_number] => 11009841
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/009841 | HIV protease inhibiting compounds | Dec 9, 2004 | Issued |
Array
(
[id] => 5011525
[patent_doc_number] => 20070282004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Use of a Cyclopentenone Prostaglandin for Delaying for the Onset and/or Preventing the Continuation of Labour'
[patent_app_type] => utility
[patent_app_number] => 10/581532
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 16804
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20070282004.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581532
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581532 | Use of a Cyclopentenone Prostaglandin for Delaying for the Onset and/or Preventing the Continuation of Labour | Dec 1, 2004 | Abandoned |
Array
(
[id] => 5160449
[patent_doc_number] => 20070173493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => '1-Oxadibenzo[e,h]azulenes for the treatment of central nervous system diseases and disorders'
[patent_app_type] => utility
[patent_app_number] => 10/595935
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7636
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20070173493.pdf
[firstpage_image] =>[orig_patent_app_number] => 10595935
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/595935 | 1-Oxadibenzo[e,h]azulenes for the treatment of central nervous system diseases and disorders | Nov 18, 2004 | Abandoned |
Array
(
[id] => 9183932
[patent_doc_number] => 08623864
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-07
[patent_title] => 'Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance'
[patent_app_type] => utility
[patent_app_number] => 10/579112
[patent_app_country] => US
[patent_app_date] => 2004-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10541
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10579112
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579112 | Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance | Nov 14, 2004 | Issued |
Array
(
[id] => 6938625
[patent_doc_number] => 20050112188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle'
[patent_app_type] => utility
[patent_app_number] => 10/988716
[patent_app_country] => US
[patent_app_date] => 2004-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14897
[patent_no_of_claims] => 83
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112188.pdf
[firstpage_image] =>[orig_patent_app_number] => 10988716
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/988716 | Composition and dosage form comprising an interferon particle formulation and suspending vehicle | Nov 14, 2004 | Issued |
Array
(
[id] => 7172617
[patent_doc_number] => 20050203092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => '4-Pyrimidinamine derivatives, pharmaceutical compositions and related methods'
[patent_app_type] => utility
[patent_app_number] => 10/987562
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18192
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203092.pdf
[firstpage_image] =>[orig_patent_app_number] => 10987562
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/987562 | 4-Pyrimidinamine derivatives, pharmaceutical compositions and related methods | Nov 11, 2004 | Abandoned |
Array
(
[id] => 7038940
[patent_doc_number] => 20050158374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Compositions and dosage forms for enhanced absorption of metformin'
[patent_app_type] => utility
[patent_app_number] => 10/978141
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14764
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158374.pdf
[firstpage_image] =>[orig_patent_app_number] => 10978141
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/978141 | Compositions and dosage forms for enhanced absorption of metformin | Oct 28, 2004 | Abandoned |
Array
(
[id] => 5000477
[patent_doc_number] => 20070043111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Use of ifenprodril in the treatment of pain'
[patent_app_type] => utility
[patent_app_number] => 10/575912
[patent_app_country] => US
[patent_app_date] => 2004-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1361
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20070043111.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575912
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575912 | Use of ifenprodril in the treatment of pain | Oct 20, 2004 | Abandoned |
Array
(
[id] => 6996304
[patent_doc_number] => 20050136082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Polymeric odor absorption ingredients for personal care products'
[patent_app_type] => utility
[patent_app_number] => 10/966365
[patent_app_country] => US
[patent_app_date] => 2004-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8156
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136082.pdf
[firstpage_image] =>[orig_patent_app_number] => 10966365
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/966365 | Polymeric odor absorption ingredients for personal care products | Oct 14, 2004 | Abandoned |
Array
(
[id] => 7070149
[patent_doc_number] => 20050245534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme'
[patent_app_type] => utility
[patent_app_number] => 10/965591
[patent_app_country] => US
[patent_app_date] => 2004-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43375
[patent_no_of_claims] => 122
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20050245534.pdf
[firstpage_image] =>[orig_patent_app_number] => 10965591
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/965591 | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme | Oct 13, 2004 | Abandoned |
Array
(
[id] => 10031428
[patent_doc_number] => 09072728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Treatment of severe distal colitis'
[patent_app_type] => utility
[patent_app_number] => 10/572667
[patent_app_country] => US
[patent_app_date] => 2004-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 11471
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10572667
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/572667 | Treatment of severe distal colitis | Sep 19, 2004 | Issued |
Array
(
[id] => 8858176
[patent_doc_number] => 08460710
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-11
[patent_title] => 'Antibiotic product, use and formulation thereof'
[patent_app_type] => utility
[patent_app_number] => 10/940265
[patent_app_country] => US
[patent_app_date] => 2004-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6726
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10940265
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/940265 | Antibiotic product, use and formulation thereof | Sep 13, 2004 | Issued |
Array
(
[id] => 5732315
[patent_doc_number] => 20060257432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Pharmaceutical formulations of xanthogenates and inhibitors of viral nucelic acid replication'
[patent_app_type] => utility
[patent_app_number] => 10/572950
[patent_app_country] => US
[patent_app_date] => 2004-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1835
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257432.pdf
[firstpage_image] =>[orig_patent_app_number] => 10572950
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/572950 | Pharmaceutical formulations of xanthogenates and inhibitors of viral nucelic acid replication | Sep 8, 2004 | Abandoned |
Array
(
[id] => 4989357
[patent_doc_number] => 20070155698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Oxazaborolidines as bacteria effectors'
[patent_app_type] => utility
[patent_app_number] => 10/570207
[patent_app_country] => US
[patent_app_date] => 2004-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11963
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20070155698.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570207
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570207 | Oxazaborolidines as bacteria effectors | Sep 1, 2004 | Abandoned |
Array
(
[id] => 4461197
[patent_doc_number] => 07879897
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-01
[patent_title] => 'Pesticidal 5-substituted-oxyalkylamino-1-arylpyrazole derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/570042
[patent_app_country] => US
[patent_app_date] => 2004-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15115
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/879/07879897.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570042
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570042 | Pesticidal 5-substituted-oxyalkylamino-1-arylpyrazole derivatives | Aug 20, 2004 | Issued |
Array
(
[id] => 5860026
[patent_doc_number] => 20060229356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Use of indomethacin and derivatives as broad-spectrum antiviral drugs and corresponding pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 10/568071
[patent_app_country] => US
[patent_app_date] => 2004-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3483
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229356.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568071
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568071 | Use of indomethacin and derivatives as broad-spectrum antiviral drugs and corresponding pharmaceutical compositions | Aug 10, 2004 | Abandoned |